Effects of Peanuts on Immunity and Cardiometabolic Risk Factors
NCT ID: NCT06159556
Last Updated: 2024-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2024-01-31
2024-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peanuts for Cardiometabolic, Brain, and Intestinal Health
NCT06867198
Cardiometabolic Effects of Pecans as a Snack
NCT05071807
Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population
NCT03194152
Eating Peanuts for Health
NCT01886326
Effects of Peanut and Peanut Butter Consumption on Blood Lipids and Glycemic Control in Adults With Type 2 Diabetes
NCT00937222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peanut group
Participants will be consuming 2 ounces of peanuts /peanut butter everyday for 12 weeks
Peanut intake
Participants will consume 2 ounces of peanuts/peanut butter for 12 weeks
control group
Participants will continue with habitual diet and abstain from eating peanuts
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peanut intake
Participants will consume 2 ounces of peanuts/peanut butter for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* bad dentures unable to chew peanuts
* regular intake of peanuts and/or other nuts (\>3 ounces/week)
* use of immune-boosting supplements
* exposure to antibiotics and corticoids immediately prior to the study
* use of other medications or supplements that can interfere with the immune functions
* Individuals that received any vaccination (i.e flu or Covid 19) 6 months prior to the start of the study
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
California Walnut Commission
OTHER
Loma Linda University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joan Sabate,DrPH, MD
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University School of Public Health
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5230190
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.